chrisvoncsefalvay/vaers-outcomes huggingface dataset:
I began to suffer all over my body, from allergic reactions to everything. Allergies to metals, plastics, wood, fabrics, dust on surfaces.; They appear as welts, itchiness, lumps on the welts; They appear as welts, itchiness, lumps on the welts; This is a spontaneous report received from a contactable reporter(s) (Consumer or other non HCP). The reporter is the patient.  A 47 year-old male patient received bnt162b2 (BNT162B2), administered in arm left, administration date 10Apr2021 10:00 (Lot number: Ew0158) at the age of 46 years as dose 1, single for covid-19 immunisation. The patient had no relevant medical history. The patient's concomitant medications were not reported. The following information was reported: MULTIPLE ALLERGIES (non-serious) with onset 17Apr2021, outcome "not recovered", described as "I began to suffer all over my body, from allergic reactions to everything. Allergies to metals, plastics, wood, fabrics, dust on surfaces."; URTICARIA (non-serious), PRURITUS (non-serious) all with onset 17Apr2021, outcome "not recovered" and all described as "They appear as welts, itchiness, lumps on the welts". Relevant laboratory tests and procedures are available in the appropriate section. Therapeutic measures were not taken as a result of multiple allergies, urticaria, pruritus. Additional information; Dose received: 3 Most recent dose details: Product COVID 19,  Brand Pfizer and Lot Number Fh8030 along with Administration date 21Nov2021, time 01:00 PM, Vaccine location (was not provided). Previous dose details: dose number 2, Previous dose product COVID 19, Previous dose brand Pfizer and lot Number Ew0179 along with administration date 01May2021, time 10:00 AM, Vaccine location(was not provided). Additional information (dose 2, dose 3) amended in narrative. , No follow-up attempts are possible. No further information is expected.
Neuropathies in hands and feet. Neurologic implications throughout body, burning pain. Brain spect abnormal. Severe joint pain, shoulders, hips, and elbows. Symptoms began about 1 year after third shot. All symptoms have progressed since Spring 2002. Informed that problems are permanent. No treatment known. Nurse follow up on 06/28/04 states: "Per review of medical records, please add the following symptoms to Box 7: hyperacusis (HYPERACUSIS), numbness (PARESTHESIA), TMJ (JOINT DIS), tinnitus (TINNITUS), myalgia (MYALGIA), reactive depression (DEPRESSION), weight loss (WEIGHT DEC), sleeping poorly (insomnia), and chronic Lyme disease (INFECT). "
experience arm pain; weakness; difficulty moving his arm; pain under his shoulder; Parson Turner Syndrome (neuritis); This is a spontaneous report from a contactable physician. A 21-year-old male patient received the second dose of BNT162B2 (PFIZER-BIONTECH COVID-19 VACCINE), via an unspecified route of administration on an unspecified date at single dose for COVID-19 immunisation. The patient medical history and concomitant medications were not reported. The patient experienced arm pain followed by difficulty moving his arm. He was requiring a sling at the time of the report, had been prescribed ketorolac tromethamine (TORADOL) and steroids but was not doing any better. He was having continued weakness and pain under his shoulder. Physician was asking for documentation or studies that had been done to determine if the vaccine had any relationship with Parson Turner Syndrome (neuritis) and recommendations for management. Outcome of the events was unknown.  No follow-up attempts are needed; information about lot/batch number cannot be obtained.; Sender's Comments: Linked Report(s) : US-PFIZER INC-2021438381 Same reporter/drug/AE, different patient
In November my cycle started which was very abnormal because I had been on a birth control (arm implant) for at least 5 years. Came back like a normal cycle then by March it was 3 weeks and by June 23 it was just nonstop no rhythm or anything. At this point me and my doctor agreed to do the hysterectomy to rid myself of these cycles. July 11th, I had the surgery during my two weeks recovery was fine. Until Saturday the 23 while I was in recovery, I started bleeding like crazy I was told if got it got any worse to call. On the 26 of July, it was out of control, and it was all due to the stitches dissolving before I had recovered. I was then rushed into an unscheduled emergency surgery because of the loss of blood. I was then told I lost so much blood I could've gone into cardiac arrest.
A report was received from a health care professional on 25Nov03, concerning a 16 month old female vaccinee who inadvertently received Fluvirin on 21Nov03. On 21Nov03 the vaccinee inadvertently received 0.25ml of Fluvirin. At the time of the report no adverse events had been reported. There was insufficient information to determine the reporters causality assessment. Update 1, 11Mar04:Further information received from a health care professional indicated that the vaccinee did not experience any adverse reaction at the time of the report. No follow up pending, all information received. See Ref: PJP200301183, PJP200400053, PJP200400052, PJP200400051, PJP200400050, PJP200400049, PJP200400048, PJP200400047, PJP200400046, PJP200400045, PJP200400044, PJP200400043, PJP200400042, PJP200400040, PJP200400039, PJP200400038,  PJP200400037.
pt recvd vax 26JUL94 in the AM;later in the afternoon devel fever of 102 & inj site rxn of erythema, swelling & tenderness (size unk);MD visit same day-given APAP;fever resolved;no further sxs;
sore arm; This is a spontaneous report from a contactable consumer (patient) via a Pfizer-sponsored program Pfizer First Connect. A male patient of an unspecified age (reported as 72, unknown unit) received BNT162B2 (PFIZER-BIONTECH COVID-19 VACCINE; lot number and expiry date: unknown), via an unspecified route of administration on 15Jan2021 at a single dose for COVID-19 immunization. The patient's medical history and concomitant medications were not reported.  The patient experienced sore arm on 15Jan2021. Outcome of the event was unknown. Patient was asking if e was allowed to drink cocktail at night and if the second dose can be administered before or after 21 days.  Information on the lot/batch number has been requested.
26 y/o M, anthrax vaccine reaction, x2 days. Pt states he had the vaccine Wednesday, and started noticing reaction Wednesday night. Pt states Wednesday night he started noticing a small, hard bump at injection site. Pt states that the bump has been getting larger, and red spots around injection site. Arm is warm to the touch and red. Pt states there is no radiation of pain down the arm. Pt states he has not had any fevers, nausea, vomiting, body aches or chills. Pt states this is his fourth vaccine and has not had any reaction to the previous vaccines.
lesion on hip; Herpes; This spontaneous case was reported by a physician and describes the occurrence of HERPES VIRUS INFECTION (Herpes) and SKIN LESION (lesion on hip) in a female patient of an unknown age who received mRNA-1273 (Moderna COVID-19 Vaccine) for COVID-19 vaccination.     No medical history was not reported by the reporter.  Concomitant products included APIXABAN (ELIQUIS) for an unknown indication.    On 08-Feb-2021, the patient received first dose of mRNA-1273 (Moderna COVID-19 Vaccine) (Intramuscular) 1 dosage form. On an unknown date, the patient experienced HERPES VIRUS INFECTION (Herpes) and SKIN LESION (lesion on hip). At the time of the report, HERPES VIRUS INFECTION (Herpes) and SKIN LESION (lesion on hip) outcome was unknown.        The action taken with mRNA-1273 (Moderna COVID-19 Vaccine) (Intramuscular) was unknown.   For mRNA-1273 (Moderna COVID-19 Vaccine) (Intramuscular), the reporter did not provide any causality assessments.   Treatment details were not reported by the reporter.
This spontaneous case was reported by a consumer and describes the occurrence of VACCINATION COMPLICATION (Potential adverse event) in a female patient of an unknown age who received mRNA-1273 (Moderna COVID-19 Vaccine) for COVID-19 vaccination. No Medical History information was reported. On an unknown date, the patient received dose of mRNA-1273 (Moderna COVID-19 Vaccine) (Intramuscular) 1 dosage form. On an unknown date, the patient experienced VACCINATION COMPLICATION (Potential adverse event). At the time of the report, VACCINATION COMPLICATION (Potential adverse event) outcome was unknown. The action taken with mRNA-1273 (Moderna COVID-19 Vaccine) (Intramuscular) was unknown. Concominant medications were not reported. Treatment information was not provided. Reporter did not allow further contact
Fever, fatigue and local cellulitis muscle pain and dark yellow urine. Tx: extra fluids/hydration and rest; Improving as of flu visit 12/11/15 resolved by mid-Dec.
Patient took the Pfizer Corona Virus shot does 1 on march 1, 2021.  He passed away on march 20, 2021.  Reported being fatigued and exhausted after taking does 1. Was sleeping up 10 hours a day.  On the day he passed, he reported being light-headed and struggling to breath.  The paramedics worked on him for 40 minutes to try and revive him.
RED, ITCHY MULTIPLE PARTS OF THE BODY.  HIVES UNDER BREAST, INNER UPPER LEGS, INNER ARMS, PALMS, BOTTOM OF FEET.
Lost consciousness. Fell to the floor. Was disoriented and not aware of time or place. He cut his forehead over his right eye. Brought to ER. They performed ct scan, EKG and blood work. All came back normal. Received 20 stitches to forehead.
Patient reports having a difficult time moving Right upper extremity and states has numbness down right arm. It is noted that he had a major reaction-"Take" and if fully immunized.
General rash. patient was given oral and topical  cortico-steroid along with antihistamine
I received my 2nd vaccine on Feb 5/2021 and my adverse event started on 02/20/2021 every time I exercise my throat gets tight and I am gasping for air. Even if I ran my throat gets tight. I went to urgent care he said it was acid reflux. He said to take medications for acid like TUMS. It didn't help then I went to a new doctor in June 2021. She said it must have something to do with my neck muscles. She advised me to move my neck muscles or do exercise. I had no idea still now what is going on with me. I feel there is something is wrong with me but never got to find it out. It's on going. I am going to see my new primary care next month on June/2022 for this issue.
Heart was beating fast; Stressed after seeing her arm; Big red spot on her right arm; Is still sore; This spontaneous case was reported by a consumer and describes the occurrence of TACHYCARDIA (Heart was beating fast), STRESS (Stressed after seeing her arm), VACCINATION SITE ERYTHEMA (Big red spot on her right arm) and VACCINATION SITE PAIN (Is still sore) in a 67-year-old female patient who received mRNA-1273 (Moderna COVID-19 Vaccine) for COVID-19 vaccination.     No medical history was provided by the reporter.  Concomitant products included AMLODIPINE for an unknown indication.    On 09-Mar-2021, the patient received first dose of mRNA-1273 (Moderna COVID-19 Vaccine) (Intramuscular) 1 dosage form. On 17-Mar-2021, the patient experienced TACHYCARDIA (Heart was beating fast), STRESS (Stressed after seeing her arm), VACCINATION SITE ERYTHEMA (Big red spot on her right arm) and VACCINATION SITE PAIN (Is still sore). The patient was treated with IBUPROFEN (ADVIL [IBUPROFEN]) at an unspecified dose and frequency. At the time of the report, TACHYCARDIA (Heart was beating fast), STRESS (Stressed after seeing her arm), VACCINATION SITE ERYTHEMA (Big red spot on her right arm) and VACCINATION SITE PAIN (Is still sore) outcome was unknown.        The action taken with mRNA-1273 (Moderna COVID-19 Vaccine) (Intramuscular) was unknown.       The patient was not planning to get the second shot.
BURNING LIPS; IRRITATION GUM; GENITAL IRRITATION; LIGHT-HEADED; BURNING TONGUE; SKIN RASH; FEELING UNWELL; This spontaneous report received from a patient concerned a female of unspecified age. The patient's weight, height, and medical history were not reported. The patient received covid-19 vaccine ad26.cov2.s (suspension for injection, route of admin not reported, and batch number: 043A21A expiry: UNKNOWN) dose was not reported, administered on 08-APR-2021 for prophylactic vaccination. No concomitant medications were reported.  On 12-APR-2021, the subject experienced burning lips. On 12-APR-2021, the subject experienced irritation gum. On 12-APR-2021, the subject experienced genital irritation. On 12-APR-2021, the subject experienced light-headed. On 12-APR-2021, the subject experienced burning tongue. On 12-APR-2021, the subject experienced skin rash. On 12-APR-2021, the subject experienced feeling unwell. The action taken with covid-19 vaccine ad26.cov2.s was not applicable. The patient had not recovered from skin rash, burning lips, irritation gum, genital irritation, light-headed, feeling unwell, and burning tongue. This report was non-serious.
24 hr flu shot localized erythema. Abx/steroid/antihistamine/histamine and induration blocher.
After receiving the shot,  I experienced a sharp pain in my shoulder and neck on the left side (same side as the shot was received).  This only lasted a couple of minutes and then I felt normal.  That evening the area where I received the shot was sore and hard to lift.  This is when I started to notice stiffness in my left elbow joint and muscle aches throughout my body.  Upon waking the following morning,  the stiffness in my elbow joint had increase and it made it difficult to bend my elbow.  At this point,  I had assumed that maybe I had pulled something or slept on it wrong.  I figured it would work itself out in a day or two.  This has not been the case.  It is now day 8,  my elbow joint is stiff with soreness and pain in the surrounding area.  I am not able to lift items as I normally would or squeeze/hold items in my  left hand without experiencing pain in that elbow or the surround muscles.  It had been uncomfortable and painful to move and bend that arm and even the simple act of straightening the elbow is difficult to accomplish.  All pain and discomfort is limited to the elbow joint and surrounding area.
fatigue; feeling distress; whole body achiness; This spontaneous case was reported by a consumer and describes the occurrence of FATIGUE (fatigue), TENSION (feeling distress) and PAIN (whole body achiness) in an 83-year-old female patient who received mRNA-1273 (Moderna COVID-19 Vaccine) for COVID-19 vaccination.     The patient's past medical history included No adverse event. Concomitant products includedMultivitamins   for supplemental purposes for an unknown indication.                                                   On 06-Mar-2021, the patient received first dose of mRNA-1273 (Moderna COVID-19 Vaccine) (Intramuscular) 1 dosage form. On 06-Mar-2021, the patient experienced FATIGUE (fatigue), TENSION (feeling distress) and PAIN (whole body achiness). At the time of the report, FATIGUE (fatigue), TENSION (feeling distress) and PAIN (whole body achiness) outcome was unknown.        The action taken with mRNA-1273 (Moderna COVID-19 Vaccine) (Intramuscular) was unknown.
Grouped vesicles mid left shoulder, elbow, ulnar aspect left hand, but also end of third finger and theriar aspect of left hand. Onset 1/09/05. Treated with Tzanck and Acyclovir for 7 days.
shingles; This case was reported by a consumer via interactive digital media and described the occurrence of shingles in a patient who received Herpes zoster (Shingles vaccine) for prophylaxis.   On an unknown date, the patient received Shingles vaccine. On an unknown date, less than a week after receiving Shingles vaccine, the patient experienced shingles. On an unknown date, the outcome of the shingles was unknown.   It was unknown if the reporter considered the shingles to be related to Shingles vaccine.  Addition details were provided as follows: The case was reported by the patient's family member. The age at vaccination was not reported. The patient got the Shingles vaccine and then got shingles that week. The follow-up would not possible as no contact details were available.
Felt lightheaded as if room was swirling.....lasting only a second or two and then left. I had to grab onto something to steady myself. This was 20 min after RSV vaccination. Experienced nausea and a feeling of being unwell.....very unpleasant......this lasted for another day and then left (today) by 6pm. Injection site tenderness.x 3 days. I know this was an RSV vaccine......but don't know manufacturer or lot number or which RSV type it was. I had an influenza 2023 vaccine on 9/4/23 with no ill effects.
Pt experienced a round red rash around suspected flu shot site (it looks like a spider bite, not 100% if it was the site of the shot). Red circle 1/2 inch in diameter. Used hydrocortisone cream it went away in a few days once he told us about it.
Patient with syncope for about 30 seconds and came around on own. Given juice and snack and continued to monitor. No further issues noted.
Patient received seasonal flu shot on the left arm, immediately after administering the vaccine, patient fainted. Patient complained of abdominal pain and throw up right after. Gave patient some water to help with stomach discomfort, had patient sit  on chair for 30 minutes, before leaving.
No additional AE details; Inbound all from HCP stating VARIVAX experienced a supported temp excursion and then was administered to patients.; This spontaneous report has been received from a medical assistant, concerning to a patient of unknown age and gender. They concomitant medications was sterile diluent (valid lot number U002746 with an expiration date on 25-JUN-2023).The patient's pertinent medical history, concurrent conditions, previous drug reactions, allergies,  were not provided.  On 03- JUN-2022, the patient was administered vaccine varicella virus vaccine live (oka/merck) (VARIVAX) subcutaneous injection (valid lot number T031383 [expiration date 15-SEP-2022]) for prophylaxis, after a temperature excursion of 9 degrees Fahrenheit (F) for 3 hours (h), 50 minutes (min) (product storage error) (dose, vaccination scheme, dose number, frequency, and anatomical location of vaccination were not provided). No previous temperature excursion was reported.  No additional adverse events (AE) details were reported.
9 days after injection site swoll up was red in about 2 inch by 3 inch area.  Tender and stayed swollen for about 5 days.
BI-lateral Pulmonary Emboli; This is a spontaneous report from a contactable physician via a company representative. The physician reported same events for four patients in his practice. This is the fourth of four reports. An elder female patient of an unknown age (70 or older) received BNT162B2 (PFIZER-BIONTECH COVID-19 VACCINE) at single dose on an unworn date via an unknown route for Covid-19 immunization. Medical history and concomitant drug were not provided. This patients in the reporting physician's practice got the Pfizer COVID-19 vaccine and developed BI-lateral Pulmonary Emboli within a month of the vaccine.  Outcome of the event was unknown.    The lot number for the vaccine, [BNT162B2], was not provided and will be requested during follow up.; Sender's Comments: Based on temporal association, the causal relationship between BNT162B2 and the event pulmonary embolism cannot be excluded. The information available in this report is limited and does not allow a medically meaningful assessment. This case will be reassessed once additional information becomes available. The impact of this report on the benefit/risk profile of the Pfizer product is evaluated as part of Pfizer procedures for safety evaluation, including the review and analysis of aggregate data for adverse events. Any safety concern identified as part of this review, as well as any appropriate action in response, will be promptly notified to Regulatory Authorities, Ethics Committees, and Investigators, as appropriate. ,Linked Report(s) : US-PFIZER INC-202101406989 Same reporter, different patient/event.
Breakthrough Covid Infection; Breakthrough Covid Infection; This is a spontaneous report received from a contactable reporter(s) (Consumer or other non HCP) from product quality group. The reporter is the patient.  A 40 year-old female patient (not pregnant) received bnt162b2 (BNT162B2), administered in arm left, administration date 21Dec2021 (Lot number: EW0196) at the age of 40 years as dose 3 (booster), single, administration date 01Mar2021 (Lot number: EL3247) at the age of 39 years as dose 2, single and (Lot number: EL3247) at the age of 39 years as dose 1, single for covid-19 immunisation. The patient's relevant medical history and concomitant medications were not reported. Patient did not receive any other vaccine in four weeks. Patient had no COVID prior vaccination. The following information was reported: DRUG INEFFECTIVE (medically significant), COVID-19 (medically significant) all with onset 20Jan2022, outcome "recovering" and all described as "Breakthrough Covid Infection". The patient underwent the following laboratory tests and procedures: sars-cov-2 test: (20Jan2022) positive, notes: Other. Therapeutic measures were not taken as a result of drug ineffective, covid-19.  No follow-up attempts are possible. No further information is expected.
Nausea, vomiting, headache, fever 102, chills, bodyaches, neck pain, dizziness
I had chills, diarrhea, congestion, fever, lethargic, very weak, felt like I had a flu virus. I used a home COVID-19 test that came back positive very quickly. I called and made an appointment to see my doctor, they did not retest me, they did prescribe the antiviral medication Paxlovid and gave me a prescription for Benzonatate. I started taking the medication on May 23, by the next day my fever was gone, I started to feel a bit better. By the fifth day in quarantine, I was feeling a bit more like myself.
NO visible  wheal present.  Pt chart indicates that pt deferred revaccination via subcutaneous route.
Covid; Covid; Headache; FACILITATED COLLECT  This is a solicited report received from contactable reporter(s) (Consumer or other non HCP) for a Pfizer sponsored program (NOT PROVIDED). The reporter is the patient. Other Case identifier(s): 21K-163-4189938-00 (Facilitating Company).  A 60 year-old female patient received bnt162b2 (BNT162B2), intramuscular, administration date 30Mar2021 (Batch/Lot number: unknown) at the age of 60 years as dose 1, single and intramuscular, administration date 29Apr2021 (Batch/Lot number: unknown) as dose 2, single for covid-19 immunisation; adalimumab (HUMIRA), subcutaneous (Batch/Lot number: unknown) for colitis ulcerative. The patient's relevant medical history and concomitant medications were not reported. The following information was reported: DRUG INEFFECTIVE (medically significant), SUSPECTED COVID-19 (medically significant) all with onset Nov2021, outcome "recovering" and all described as "Covid"; HEADACHE (non-serious) with onset 2021, outcome "recovered" (2021), described as "Headache".  Causality for Humira (Adalimumab)  The reporter's causality for the event(s) of COVID and headache after vaccine was not provided.  Causality for Pfizer Biontech Covid-19 Vaccine  The reporter's causality for events of COVID-19 and Headache provided as probable.   The lot number for bnt162b2 was not provided and will be requested during follow up.; Sender's Comments: Based on the available information and a possible contributory role of the suspect product BNT162B2 to the development of events drug ineffective, suspected covid19, headache cannot be totally excluded.